References in periodicals archive ?
The US Food and Drug Administration has granted both Breakthrough Therapy Designation and Orphan Drug Designation to US-based clinical-stage biopharmaceutical company PellePharm for topical patidegib for reduction of the life-long serious clinical morbidity and disease burden of persistently developing basal cell carcinomas in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS), a rare genetic disease also known as Gorlin Syndrome, the company said.
Basal cell carcinoma displays a variety of growth patterns that may be broadly divided into nonaggressive (indolent) and aggressive types.
There were 98 cases of basal cell carcinoma, 49 cases of squamous cell carcinoma, and 34 cases of malignant melanoma.
Classically, they are thought to arise from epidermal basal cell layer, although current theory supports either a follicular or interfollicular stem cell origin.
According to the Skin Cancer Foundation, basal cell carcinoma stems from abnormal, uncontrolled growths or lesions that appear in the skin's basal cells.
Cutaneous markers of photo-damage and risk of basal cell carcinoma of the skin: a meta-analysis.
Keywords: Basal cell carcinoma; cytology; dog; pathology
In 2011, we removed a benign basal cell tumor from a wild born captive cheetah living on a Namibian farm.
The cells were arranged into well-demarcated islands and strands, which appeared to be raised from the basal cell layer of the overlying epidermis and invaded into the underlying connective tissue (figure 3).
Among these tumors, basal cell carcinomas are less common and less aggressive in nature.
AbstractBasosquamous cell carcinoma is a subtype of basal cell cancer.
USPRwire, Mon Jun 30 2014] Global Markets Direct's, 'Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2014', provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma)'s therapeutic pipeline.

Full browser ?